久久99国产亚洲高清-久久99国产亚洲高清观看首页-久久99国产亚洲精品观看-久久99国产一区二区-久久99国产一区二区三区-久久99国产综合精品

樹(shù)人論文網(wǎng)一個(gè)專(zhuān)業(yè)的學(xué)術(shù)咨詢(xún)網(wǎng)站!!!
樹(shù)人論文網(wǎng)
學(xué)術(shù)咨詢(xún)服務(wù)

EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

來(lái)源: 樹(shù)人論文網(wǎng) 瀏覽次數(shù):395次
Bimonthly
創(chuàng)刊時(shí)間:1991
周期:Bimonthly
ISSN:0939-6411
影響因子:4.708
是否開(kāi)源:No
年文章量:262
錄用比:66%
學(xué)科方向:藥學(xué)
研究方向:醫(yī)學(xué)
通訊地址:ELSEVIER SCIENCE BV, PO BOX 211, AMSTERDAM, NETHERLANDS, 1000 AE
官網(wǎng)地址:http://www.elsevier.com/wps/find/journaldescription.cws_home/600120/description
投稿地址:http://ees.elsevier.com/ejpb/
網(wǎng)友分享經(jīng)驗(yàn):約3.0個(gè)月

EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS雜志中文介紹

《歐洲藥學(xué)和生物藥理學(xué)雜志》提供了一個(gè)出版來(lái)自制藥技術(shù)、制藥生物技術(shù)和生物藥理學(xué)領(lǐng)域的新穎和創(chuàng)新研究的媒體。主題包括:?藥物和藥物前設(shè)計(jì)、藥物穩(wěn)定性和藥物開(kāi)發(fā)?藥物和生物制藥的開(kāi)發(fā)、配方和制造?物理制藥、藥物傳遞系統(tǒng)、控制釋放系統(tǒng)和藥物靶向?生物藥劑學(xué)?藥物分析和藥物包裝?質(zhì)量控制、GMP和法規(guī)方面?醫(yī)療設(shè)備“三的規(guī)則”編輯和編輯委員會(huì)制定了“3的規(guī)則”。在投稿前,作者必須考慮以下三個(gè)標(biāo)準(zhǔn),并在工作中設(shè)定完整的編輯審核流程:1. 這篇論文必須報(bào)道在制藥技術(shù)、生物制藥和重要的制藥生物技術(shù)方面的最新進(jìn)展2. 一篇論文必須基于深入和廣泛的研究,使用已建立的或描述良好的方法,包括適當(dāng)?shù)目刂啤Q芯勘仨毷羌僭O(shè)驅(qū)動(dòng)的,結(jié)論必須得到數(shù)據(jù)的支持。3.手稿中描述的研究必須代表一種新穎的方法這些規(guī)則也被用作同行審稿的指導(dǎo)方針。請(qǐng)按此瀏覽“規(guī)則三”

EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS雜志英文介紹

The European Journal of Pharmaceutics and Biopharmaceutics provides a medium for publication of novel and innovative research from the areas of Pharmaceutical Technology, Pharmaceutical Biotechnology and Biopharmaceutics.Topics covered include:? Drug and pro-drug design, drug stability and drug development? Development, formulation and manufacturing of pharmaceuticals and biopharmaceuticals? Physical pharmacy, drug delivery systems, controlled release systems and drug targeting? Biopharmaceutics? Pharmaceutical analysis and pharmaceutical packaging? Quality control, GMP and regulatory aspects? Medical devices"The Rules of 3"The Editors and Editorial board have developed the "Rules of 3". Authors must consider the following three criteria before they submit a manuscript and set the whole process of editing and reviewing at work:1. The paper must report on recent advances in pharmaceutical technology, biopharmaceutics and pharmaceutical biotechnology of major importance2. A paper must be based on a thorough and extensive study, using established or well-described methods and including proper controls. Research must be hypothesis-driven and conclusions must be supported by the data presented.3. The study described in the manuscript must represent a novel approachThe rules are also used as guidelines for the peer review of manuscripts. CLICK HERE to view the "Rules of 3".

EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS影響因子